First experience of liver transplantation for HIV-positive patients in Russia

The article presents the results of liver transplantation in five HIV-infected recipients with irreversible liver damage. It is shown that four of them survived in the long-term period and are observed in a stable condition, and the only death in the recipient was not related to the HIV infection. The experience in the treatment of these patients was summarized. Analysis of the first results of liver transplantation in HIV-infection in Russia shows its validity and clinical efficacy. The only lethal case is connected with the initial extremely grave condition of the recipient and his age. Two cases of surgical traumatism, lack of consistent vaccination in the preoperative period, as well as lack of patients with hepatocellular cancer, small number of observations are obvious drawbacks of our first experience and should be corrected in the future. The success of a complex and multidisciplinary program of organ transplantation in HIV infection is impossible without participation of HIV-infectionists in the transplantation team.

1. Wyndham-Thomas C, Delforge M, Mulkay JP, De Wit S. Barriers to liver transplantation in hi infected patients. Acta Clinica Belgica. 2013;68–5.

2. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16(12):1663–1667.

3. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study. Arch Intern Med. 2006;166(15):1632–1641.

4. Peters MG. End-stage liver disease in HIV disease. Top HIV Med. 2009;17(4):124–128.

5. Sawinski D, Goldberg DS, Blumberg E, Abt PL, Bloom RD, Forde KA. Beyond the NIH multicenter HIV transplant trial experience: outcomes of HIV+ liver transplant recipients compared to HCV+ or HIV+/HCV+ coinfected recipients in the United States. Clin Infect Dis. 2015;61:1054–1621.

6. Miro JM, Grossi PA, Durand CM. Challenges in solid organ transplantation in people living with HIV. Intensive Care Med. 2019;45(3):398–400.

7. Johnston B, Conly J. Solid organ transplantation and HIV: A changing paradigm. Can J Infect Dis Med Microbiol. 2008;19(6):425–429.

8. Stock PG, Fung J. Viable strategies to facilitate liver transplantationfor human immunodeficiency virus coinfection. Liver Transpl. 2009;15(9):1003–1006.

9. Fung J, Eghtesad B, Patel-Tom K, DeVera M, Chapman H, Ragni M. Liver transplantationin patients with HIV infection. Liver Transpl. 2004;10(10 Suppl 2):S39-53.

10. Murray KF, Carithers RL Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005;41(6):1407–1432. Eurotransplant Manual | Eurotransplant [Internet]. http://www.eurotransplant.org/cms/index.php.

11. Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. J Int AIDS Soc. 2011;14:16.

12. Suk KT, Baik SK, Yoon JH et al. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18(1):1–21.

13. Husson J, Stafford K, Bromberg J, et al. Association between duration of Human Immunodeficiency Virus (HIV)–1 viral suppression prior to renal transplantation and acute cellular rejection. Am J Transplant. 2017;17:551–556.

14. Alqahtani SA, Larson AM. Adult liver transplantation in the USA. Curr Opin Gastroenterol. 2011; 27(3):240–247.

15. Suarez JF, Rosa R, Lorio MA, et al. Pre-transplant CD4 count influences immune reconstitution and risk of infectious complications in HIV+ kidney allograft recipients. Am J Transplant. 2016;16:2463–2472.

16. Blumberg EA, Stock P. Solid organ transplantation in the HIV-infected patient. Am J Transplant. 2009;9 Suppl 4:S131–135.

17. Peters MG. End-stage liver disease in HIV disease. Top HIV Med. 2009;17(4):124–128.

18. Murillas J, Rimola A, Laguno M, et al. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl. 2009;15(9):1133–1141.

19. Subramanian A, Sulkowski M, Barin B, et al. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010;138(1):159–164.

20. Stock PG, Roland ME. Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation. 2007;84(5):563–571.

21. Merchante N, Girуn-Gonzбlez JA, Gonzбlez-Serrano M, et al. Survival and prognostic factors of HIV -infected patients with HCV-related end-stage liver disease. AIDS. 2006;20(1):49–57.

22. Pineda JA, Garcia-Garcia JA, Aguilar-Guisado M, et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology. 2007;46(3):622–630.

23. Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS. 2004;18(17):2285–2293.

24. Ragni MV, De Vera ME, Roland ME, et al. Liver transplant outcomes in HIV(+) haemophilic men. Hemophilia. 2013;19:134–140.

25. Boyarsky BJ, Hall EC, Singer AL, Montgomery RA, Gebo KA, Segev DL. Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant. 2011;11(6):1209–1217.

26. Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS. 2005;19 Suppl 3:S227–237.

27. Miro J, Aguero F, Laguno M, et al. Management of ESLD in HIV Coinfection. In: Hepatology-A Clinical Textbook. Flying Publishers. 2010:353-365.

28. Grossi PA. Update in HIV infection in organ transplantation. Curr Opin Organ Transplant. 2012;17(6):586-593.

29. Agüero F, Forner A, Manzardo C et al. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular cancer. Hepatology. 2016;63:488–498.

30. Nunez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology. 2010;52(3):1143–1155.

31. Yaremin B.I., Nazarov P.K., Alekberov K.F., Konstantinov D.Yu., Kudinova E.V., Maslikova U.V., Novruzbekov M.S. New challenges to infectious safety in the implementation of medical activities related to organ and tissue donation for transplantation. Transplantologiya. The Russian Journal of Transplantation. 2020;12(2):135–142. https://doi.org/10.23873/2074-0506-2020-12-2-135-142 (In Russ).

32. Novruzbekov M.S., Gulyaev V.A., Lutsyk K.N., Akhmetshin R.B., Olisov O.D., Magomedov K.M., Kazymov B.I., Yaremin B.I., Khubutiya M.S. Liver transplantation program at N. V. Sklifosovsky research institute of emergency medicine: stages, achievements, and outlooks. Bulletin of the Medical Institute "REAVIZ" (Rehabilitation, Doctor and Health). 2020;(3):162–173. (In Russ).